Exhibit 32(b)

              CERTIFICATION OF CHIEF FINANCIAL OFFICER
                 PURSUANT TO 18 U.S.C. SECTION 1350,
                       AS ADOPTED PURSUANT TO
            SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In   connection  with  the  IGENE  Biotechnology,   Inc.   (the
"Company") Quarterly Report on Form 10-QSB for the period ended June
30,  2007,  as filed with the Securities and Exchange Commission  on
the  date  hereof  (the  "Report"), I, Edward J.  Weisberger,  Chief
Financial  Officer  of the Company, certify pursuant  to  18  U.S.C.
Section  1350,  as adopted pursuant to Section 906 of the  Sarbanes-
Oxley Act of 2002, that, to the best of my knowledge:

          (1).  The  Report  fully complies with the requirements of
          Section  13(a)  or 15(d) of the Securities Exchange Act of
          1934, as amended; and

          (2).  The  information  contained  in  the  Report  fairly
          presents,   in   all   material  respects,  the  financial
          condition and results of operations of the Company.


Date: December 11, 2007              By: /S/ EDWARD J. WEISBERGER
                                         ___________________________
                                             EDWARD J. WEISBERGER
                                             Chief Financial Officer




A  signed original of this written statement required by Section 906
has been provided to the Company and will be retained by the Company
and furnished to the Securities and Exchange Commission or its staff
upon request.